Accelerating the development of biomarkers for drug safety : workshop summary /

"Biomarkers can be defined as indicators of any biologic state, and they are central to the future of medicine. As the cost of developing drugs has risen in recent years, reducing the number of new drugs approved for use, biomarker development may be a way to cut costs, enhance safety, and prov...

Full description

Saved in:

Bibliographic Details
Corporate Author:	Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation
Other Authors:	Olson, Steve, 1956-, Robinson, Sally, Giffin, Robert B.
Format:	Electronic eBook
Language:	English
Published:	Washington, D.C. : National Academies Press, ©2009.
Subjects:	Biochemical markers > Congresses. Drugs > Safety measures > Congresses. Drugs > Testing > Congresses. Drugs > Side effects. Biochemical markers. Drugs > Design. Drug-Related Side Effects and Adverse Reactions Biomarkers. Drug Design Drug Discovery Congress proceedings (reports) Conference papers and proceedings.
Online Access:	Full text (Emerson users only) Full text (Emmanuel users only) Full text (NECO users only) Full text (MCPHS users only) Full text Full text (Wentworth users only)

Full text (Emerson users only)
Full text (Emmanuel users only)
Full text (NECO users only)
Full text (MCPHS users only)
Full text
Full text (Wentworth users only)

Emerson

Holdings details from Emerson
Call Number:	ProQuest

Emmanuel

Holdings details from Emmanuel
Call Number:	ProQuest

NECO

Holdings details from NECO
Call Number:	ProQuest

MCPHS

Holdings details from MCPHS
Call Number:	NCBI ProQuest

Wentworth

Holdings details from Wentworth
Call Number:	ProQuest